For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.
(Image credit: Michael Dantas/AFP via Getty Images)
Subscribe to:
Post Comments
(
Atom
)
Post a Comment